[1] |
WANG Yuhui, WANG Jingpeng, CHEN Bei, WANG Yaru, LI Tangliang.
Research progresses of nonsense-mediated mRNA decay in tumorigenesis and cancer therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 930-936.
|
[2] |
LI Ning, ZHANG Hui, ZHOU Junhui.
Effect of sub-anesthetic dose of esketamine on chronic post-surgery pain in patients undergoing radical mastectomy of breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(6): 671-679.
|
[3] |
YU Dan, LIU Zongtao, YAN Xiaohong, CHENG Jing, LI lin.
Effects of osthole on renal oxidative stress injury in aged spontaneously hypertensive rats by regulating PI3K/Akt/mTOR signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 277-282.
|
[4] |
ZHANG Tao, WANG Ruowei, FU Jialin, GAO Yue, HU Mingyuan, FANG Zhengmei, CHEN Yan, YAO Yingshui.
Exploring the effect and mechanism of α-Linolenic acid on neuroinflammation based on network pharmacology and in vitro experiments
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1110-1119.
|
[5] |
BAO Bahu, LIU Weiying, YE Yucai, CHEN Guorong, SUN Jingzi, HU Aoyan.
Research progress of miRNA in asthma: airway inflammation and endotype
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1194-1200.
|
[6] |
LIAO Mengling, WANG Yan, LUO Jing, WANG Nuoyan, HUA Ling, ZHANG Yu, DENG Fei, YUAN Yue, ZHOU Jun, ZHOU Hong.
Molecular mechanism of artesunate attenuates the release of proinflammatory cytokines from macrophages
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 969-978.
|
[7] |
ZHAO Lingzhi, HE Yanjun, XIE Jianqin, YOU Chongge.
Research progress on therapeutic role of recombinant human soluble thrombomodulin in atherosclerosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 832-840.
|
[8] |
HOU Ruiying, GUO Lige, JIAO Weijie, DU Lei, WU Guiyue, ZHAO Xu.
Effects of Xiaokeshu recipe on levels of serum inflammatory factors in type2 diabetic rats and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 377-382.
|
[9] |
NING Sisi, ZHAO Yuhong, YAN Lei, TANG Minna, ZHANG Ningzhi, ZHANG Yongqiao, CUI Zhaoqiang.
Controversies over the targets of controlling blood pressure in hyper- tensive patients with chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 463-467.
|
[10] |
HE Xinyu, ZHONG Xia, LIU Peng, TAN Ruizhi.
Hederagenin improves psoriasis skin lesions by inhibiting macrophage mincle-mediated inflammation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(12): 1339-1346.
|
[11] |
MENG Tingting, GAO Hongli, GAO Yifan, ZHANG Qinglan, YU Xiaojing.
Central mechanism of curcumin on the paraventricular hypothalamic nucleus of high salt induced hypertension rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(12): 1357-1364.
|
[12] |
KANG Qian, XIU Minghui, ZHANG Xueyan, YANG Dan, WANG Shuwei, HE Jianzheng, GONG Hongxia, CAO Wangjie, SU Yun.
Molecular mechanism of high altitude hypoxia induced intestinal homeostasis imbalance and research progress of traditional Chinese medicine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(12): 1391-1402.
|
[13] |
ZHU Ruifang, GUO Dongkai, ZHI Hui, JIANG Yiguo, ZHANG Yueling, QIAN Xiaoping, JI Shiliang.
Exploring the mechanism of elemene synergistic bortezomib against multiple myeloma by ROS-NF-κB-p38MAPK pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1219-1226.
|
[14] |
SHEN Chang, AI Kelong, HU Changping.
Research progress in the regulation of hypoxic pulmonary hypertension by hypoxia-inducible factor-1 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 114-120.
|
[15] |
FU Hong, TIAN Lei.
Individualized precision therapy for patients with ischemic stroke and hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 870-876.
|